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Abstract Consumption of a plant-based diet has been
associated with prevention of the development and pro-
gression of cancer. We have developed strategies to inhibit
cancer development and its spread by targeting common
mechanisms used by all types of cancer cells that decrease
stability and integrity of connective tissue. Strengthening of
collagen and connective tissue can be achieved naturally
through the synergistic effects of selected nutrients, such as
lysine, proline, ascorbic acid and green tea extract (NM).
This micronutrient mixture has exhibited a potent antican-
cer activity in vivo and in vitro in a few dozen cancer cell
lines. Its anti-cancer effects include inhibition of metastasis,
tumor growth, matrix metalloproteinase (MMP) secretion,
invasion, angiogenesis, and cell growth as well as induction
of apoptosis. Many cancers are often diagnosed at later
stages, when metastasis has occurred, which standard
treatment has been unable to control. Our studies on NM
effects on hepatic and pulmonary metastasis demonstrated
profound, significant suppression of metastasis in a murine
model. Evaluation of effects of NM on xenografts in
murine models demonstrated significant reduction in tumor
size and tumor burden in all human cancer cell lines tested.
In vitro studies demonstrated that NM was very effective in
inhibition of cell proliferation (by MTT assay), MMP
secretion (by gelatinase zymography), cell invasion
(through Matrigel), cell migration (by scratch test), induc-
tion of apoptosis (by live green caspase) and induction of
pro-apoptotic genes in many diverse cancer cell lines.
Furthermore, in vivo and in vitro studies of effects of
individual micronutrients compared to their specific com-
bination demonstrated synergistic effects resulting in
improved anticancer potency.
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1 Introduction
In 2009, there were 562,340 cancer deaths overall,
including 159,390 deaths from lung cancer; 49,920 from
cancer of the colon/rectum; 40,610 from female breast
cancer; 35,240 deaths from cancers of the pancreas; and
27,360 from prostate cancer. Despite extensive use of
conventional therapies, cancers such as liver, intrahepatic
bile duct, esophageal, and pancreatic continue to increase
[1]. Furthermore, cancers are often diagnosed at a later
stage, when metastasis has occurred, which standard
treatment has been unable to control. Standard cancer
treatments, which have been largely unsuccessful, generally
involve a combination of surgery, multiple chemotherapeu-
tic agents, and ionizing radiation. Evaluation of clinical
trials conducted between 1990 and 2004 on 22 types of
cancer showed that chemotherapy could increase the chance
of 5-year survival by merely 2.1% [2]. At the same time, it
is not effective in treating melanoma, uterine, prostate, and
kidney cancers. The main reasons behind disappointing
outcomes of chemotherapy are its severe toxicity, immune
involvement, and genotoxicity, giving rise to new cancers,
as well as development of drug resistance by cancer cells.
In addition to being unsuccessful in treating cancer,
standard cancer treatments are associated with high costs,
which have led to the immense increased cost of healthcare.
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1.1 Natural approaches in cancer therapy
Numerous studies indicate that consumption of a plant-
based diet has preventive effects on cancer development
and its progression [3, 4]. Many natural compounds such as
herbal extracts, vitamins (i.e., vitamin C) and micro-
nutrients have been used in cancer treatment; however, the
application of most of natural approaches have been largely
based on traditional use and personal experiences with no
clear understanding of their cellular targets and mechanisms
of action. Research in the area of natural health has been
limited and progress slow due to lack of funding for
investigations of natural compounds, as they are not
patentable and thus would result in low profits.
Since 90% of cancer deaths occur secondary to metastasis,
any successful anti-cancer treatment has to target this stage of
cancerdevelopment.Dr.Rathandhiscolleagueshavepaveda
new direction in the therapeutic use of micronutrients to
control cancer growth and metastasis by targeting common
pathomechanisms involved in growth and invasion for all
types of cancer. A major breakthrough by Dr Rath proposed
that collagen stability is the most effective and universal
approach to controlling cancer [5]. In this aspect, controlling
matrix proteolytic degradation and enhancing extracellular
matrix (ECM) structure and its integrity are key steps
towards curbing cancer invasiveness and tumor growth.
Studies by Almholt et al. [6]h a v ed e m o n s t r a t e dl i m i t e d
metastasis in serine (u-PA) deficient mouse model. Also
highly metastatic cancer cells secrete higher amounts of
matrix metalloproteinases (MMPs) than do poorly metastatic
cells, demonstrating that the invasive and metastatic abilities
of these cancer cells correlate with an ability of these
enzymes to degrade basement membranes [7, 8]. Since this
process is involved not only in metastasis, but also in
angiogenesis and tumor growth, control of proteolytic
activity of ECM provides an opportunity to modulate key
common aspects of malignancy.
A major structural protein for ECM and basement
membrane is Type IV collagen. Therefore, type IV collage-
nases MMP-2 (72-kd gelatinase A) and MMP-9 (92-kd
gelatinase B) have been the focus of research, especially since
MMP-2 and MMP-9 expression is associated with cancer cell
invasionandiselevatedinavarietyofmalignancies[9, 10]. A
significant association has been reported between tumor
aggression and increased levels of MMP-2 and MMP-9 in
many experimental and clinical studies [11, 12]. The activity
of MMPs on the degradation of the ECM plays a critical role
in the formation of tumors and metastasis and has been
found to correlate with the aggressiveness of tumor growth
and invasiveness of the cancer [8, 12].
1.2 Novel approach to cancer through nutrient synergy
Rath and Pauling [5] suggested targeting plasmin-mediated
connective tissue degradation as a universal approach to
controlling common pathomechanisms of cancer. They
proposed the use of nutritional components, such as vitamin
C and lysine and lysine analogs. Lysine interferes with the
activation of plasminogen into plasmin by tissue plasmin-
ogen activator by binding to plasminogen active sites,
thereby affecting the plasmin-induced MMP activation
cascade [5]. Our subsequent studies confirmed the approach
d e s c r i b e db yR a t ha n dP a u l i n g[ 5]a n dr e s u l t e di n
identifying a novel formulation composed of lysine,
ascorbic acid, proline and green tea extract and other
micronutrients (NM) which has shown significant antican-
cer activity against a large number (∼40) of cancer cell
lines, blocking cancer growth, tissue invasion, and MMP
expression both in vitro and in vivo [13, 14]. Furthermore,
NM demonstrated significant antiangiogenic activity utiliz-
ing the chorioallantoic membrane assay in chick embryos
and bFGF-induced vessel growth in C57BL/6 J female
mice in the mouse Matrigel plug assay [15]. In addition, in
vitro, NM decreased the expression of pro-angiogenic
factors of VEGF, angiopoietin-2, bFGF, PDGD, and
TDGβ-1 by U2OS cells [15].
1.3 Defining active compounds
The NM was formulated by selecting nutrients that act on
critical physiological targets in cancer progression and
metastasis. The anticancer effects of the individual con-
stituents of the NM have been reported in both clinical and
experimental studies. Adequate supplies of ascorbic acid
and the amino acids lysine and proline are essential for
optimal ECM formation and structure as these nutrients
insure proper synthesis and hydroxylation of collagen
fibers. Manganese and copper are also essential for collagen
formation. Lysine contributes to ECM stability as a natural
inhibitor of plasmin-induced proteolysis [5, 16]. Green tea
extract has been shown to control cancer cell growth,
metastasis, angiogenesis, and other aspects of cancer
progression [17–23].
N-acetyl cysteine and selenium have been observed to
inhibit MMP-9 and invasive activities of tumor cells, as
well as migration of endothelial cells through ECM [24–
26]. Ascorbic acid has been reported to exert cytotoxic
and antimetastatic actions on malignant cell lines [27–29];
in addition, low levels of ascorbic acid have been reported
in cancer patients [30, 31]. Arginine is a precursor of nitric
oxide (NO); any deficiency of arginine can limit the
production of NO, which has been shown to predomi-
nantly act as an inducer of apoptosis, as in breast cancer
cells [32].
530 Cancer Metastasis Rev (2010) 29:529–542Combining these micronutrients expands metabolic
targets maximizing the biological impact with lower doses
of components by nutrient synergy. Furthermore, effective
lower doses of components using nutrient synergy also
assure overcoming absorption barriers characteristic for
high vitamin doses.
2 Micronutrient synergy enhances anticancer effects
of micronutrients
The synergistic anticancer effect of micronutrients is
exemplified in the study of Kale et al. [33]o nt h e
treatment of N-methyl-N-nitrosourea (MNU)-induced
mammary tumors in Wistar rats. Different micronutrient
treatment regimens were provided after rats had developed
palpable tumors to correspond to intervention treatment
approaches in clinical settings. The combination of micro-
nutrients NM (which contains 30 mg green tea extract
(GTE)) showed improvement over 30 mg GTE alone, and
addition of quercetin and other micronutrients further
enhanced the antitumor effect. Tumors in the group of rats
treated with NM+GTE+quercetin not only were smaller
than those in other groups, but also the number of
carcinomas was reduced to six compared to 24 in the
positive control and 10–14 in the other groups, as shown
in Table 1. These results demonstrate the superior
treatment of tumors by the cooperative effect of micronu-
trient synergy. In a previous study, the NM was shown to
prevent incidence, tumor weight and tumor burden in
female Sprague–Dawley rats (n=20) that received a single
intraperitoneal (IP) dose (50 mg/kg) of MNU. Two weeks
after MNU injection, the animals were divided into two
groups and fed either Purina chow or with NM (0.5%)-
supplemented Purina chow. After 24 weeks, the group of
rats receiving the NM diet showed a reduction in tumor
incidence by 68.4%, mean tumor weight by 78% (p=
0.0001), and tumor burden 60.5% (p=0.0001) compared
to the control group of rats. In addition, the rats in the
control group developed large adenocarcinomas, including
increased mitotic index and prominent angiogenesis, while
those in the NM-supplemented group developed small
adenomas with low mitotic index [34].
Another study, an in vitro study, evaluated the potency of
the components EGCG and GTE independently compared
to their combination with other micronutrients (NM) on
modulation of MMP-2 and MMP-9 secretion patterns in
four cancer cell lines expressing MMP-2, MMP-9, or both.
Investigation of the comparative effects of GTE and EGCG
to NM at equivalent amounts found in 50, 100, 250, 500,
and 1,000 μg/mL concentrations of NM in uniduced and
PMA-treated cancer cell lines (fibrosarcoma, hepatocellular
carcinoma, glioblastoma, and leimyosarcoma) demonstrat-
ed the superior inhibitory action of NM over GTE and
EGCG on secretion of MMPs. The superior potency of NM
over GTE and EGCG can be understood from the more
comprehensive treatment offered by the combination of
nutrients in NM over individual components of NM since
MMP-2 and MMP-9 are mediated by differential pathways.
NM components LPA (a mixture of lysine, proline, and
ascorbic acid), N-acetyl cysteine, and selenium indepen-
dently had no effect on MMP-2 and MMP-9 expression by
these cancer cell lines. Thus NM, which comprises a
mixture of all these components, demonstrated superior
inhibitory activity on MMP secretion from a synergistic,
rather than from an additive effect. This study is significant
as it suggests the importance of nutrients working in
cooperation to more effectively treat complex biochemical
pathways. Figure 1 provides the zymograms and densito-
metric analyses of MMP-2 and –9 secretion by PMA-
induced fibrosarcoma HT-1080 cells treated with the
different micronutrient regimens,
2.1 Nutrient synergy controls metastasis
Our experimental results have confirmed the effectiveness
of the micronutrient mixture in controlling metastasis and
invasive parameters.
Table 1 Comparative effects of micronutrient regimens in MNU-induced mammary tumors
Treatment Number of
Tumors/rat
Size of
tumors/rat
(cc)
Weight of
tumors/rat (g)
Number of carcinomas (C)
and benign tumors (BT)
No treatment (positive control) 4.0±0.89 10.36±6.00 5.71±2.39 24 C, 1 BT
Green Tea Extract (30 mg) 2.0±1.09 7.27±6.32 5.33±4.72 14 C, 5 BT
NM 130 mg (containing 30 mg GTE) 2.0±1.05 4.13±2.74 1.70±1.11 14 C, 10 BT
NM 130 mg+N (202 mg ascorbic acid, 155 mg lysine-
HCl, 12 mg proline, 36 mg citrus flavonoids)
1.4±0.81* 3.39±2.42 1.71±1.34 10 C, 15 BT
N+quercetin 0.3 mg 1.4±0.95* 3.52±2.94 1.59±1.25 12 C, 10 BT
NM+N+quercetin 0.3 mg 1.0±0.53
a 2.69±1.76
a 1.35±0.93
a 6C , 1 5B T
aSignificantly differed from positive control group values (p<0.05) by Student’s t test
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Pulmonary metastasis was studied in 6–7w e e k - o l df e m a l e
C57BL/6 mice, which were divided into six groups of six
mice each [35]. Groups 1–4 were injected via tail vein with
B16FO melanoma cells (5×10
4/mouse), group 5 was
injected in the tail vein with the same number of B16FO
melanoma cells pretreated with NM (500 μg/mL for 18 h),
and group 6 (untreated control) was injected with the vehicle
saline. Subsequently, the mice were placed on the following
diet regimens and administration routes for NM: groups 1
and 5 were fed Purina mouse chow, the control diet; group 2
mice were given NM IP (4 mg/mouse, 3×/week×2 weeks)
and fed the control diet; group 4 was give NM intravenously
(IV; 4 mg/mouse, 3×/week×2 weeks and fed the control
diet). Group 6 mice were fed the control diet. Two weeks
later, the mice were sacrificed, and their lungs were excised,
weighed, and processed for histopathologic examination.
The weights of the lungs were obtained and the number of
metastases and number of cells in each metastatic lesion
were counted. Lungs isolated from mice injected with 5×10
4
B16FO cells and fed NM 0.5% diet (group 2) had fewer
metastatic colonies (by 63%, p<0.0001) than did the lungs
of mice fed the control diet (group 1), as shown in Figs. 2, 3,
and 4. Pulmonary colonization was inhibited by 86% (p<
0.0001) in mice receiving NM by IP and IV injections
(groups 3 and 4). The lungs from mice injected with viable
melanoma cells pretreated with NM (group 5) were free from
any metastasis. Thus, exposing melanoma cells to NM
inhibited their ability to metastasize without the need for
diet supplementation, suggesting profound changes on a
cellular level.
2.1.2 Hepatic metastasis
Highly metastatic melanoma is resistant to existing thera-
pies. Hepatic metastasis was studied in athymic nude mice,
Fig. 1 Comparative effects of EGCG, GTE, and NM on MMP-2 and
MMP-9 expression of PMA-treated human fibrosarcoma HT-1080
cells. a–b Gelatinase zymograms of HT-1080 cells showing dose-
dependent inhibition of MMP-2 and MMP-9 expression. NM was the
most potent followed by GTE and EGCG. a 1 markers, 2 control, 3–5
50 μg/mL NM EQ of EGCG, GTE, and NM, respectively; 6–
8 100 μg/mL NM EQ of EGCG, GTE, and NM, respectively. b 1
markers, 2 control, 3–5 250 μg/mL NM EQ of EGCG, GTE, and NM,
respectively; 6–8 500 μg/mL NM EQ of EGCG, GTE, and NM,
respectively. c–d Quantitative densitometry showing comparative
effects of NM, GTE and EGCG on HT-1080 cell (c) MMP-2 and
(d) MMP-9 expression
Fig. 2 Effect of NM on pulmonary colonization of B16FO cells (5×
10
4) injected in C57BL/6 mice
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6 B16FO melanoma
cells by injection into the spleen and divided into two
groups [36]. The control group of mice received Purina
mouse chow and the NM group received the regular diet
supplemented with NM 0.5%. After 2 weeks, animals were
sacrificed and spleens, livers, kidneys, and lungs were
excised from all animals, examined, weighed, and pro-
cessed for histology. The control mice developed large
black spleens and livers indicating growth in the spleen and
metastasis to the liver. However, the mice supplemented
with NM not only showed less tumor growth in the spleen
as the Control mice, but also drastically reduced metastasis
to the liver (Figs. 5a–d). Intrasplenic tumor growth (mean
spleen weight) was reduced significantly (by 64%, p=
0.001) in the NM-supplemented group compared to the
control group (Table 2). Hepatic metastasis in NM-
supplemented mice was reduced by 55% (p=0.006)
compared to the control group, based on mean liver weights
Fig. 3 Effect of NM on lungs of C57Bl/6 mice injected with B16FO cells (5×10
4): gross lung photographs. Left to right: group 1 control diet,
group 2 NM diet, group 3 NM IP, group 4 NM IV, group 5 NM pretreated cells
Fig. 4 Effect of NM on pulmo-
nary colonization of B16-FO
cells (5×10
4) injected in
C57BL/6 mice: histology.
a Control diet 40×, b control
diet 200×, c NM 0.5% diet 40×,
d NM 4 mg IP 200×, e NM-
pretreated cells 40×, f untreated
control 200×
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and lungs was evident. In conclusion, these results suggest
that NM has potential in suppression of tumor metastasis.
In the liver sections of control mice, multiple, nodular,
metastatic lesions replaced most of the examined liver. In
contrast, the liver sections of NM-supplemented mice
showed only two to five small metastases. We also studied
the effect of NM dietary treatment on the survival time of
C57BL/6 mice after receiving an injection of 10
6 B16FO
cells IP [37]. Group 1 (n=6) received no B16FO cells and
regular Purina mouse chow, group 2 (n=6), 10
6 B16FO
cells IP and regular Purina mouse chow, group 3, 10
6
B16FO cells IP and 0.5% NM-supplemented Purina mouse
chow, and group 4, 10
6 B16FO cells IP, regular Purina
mouse chow and 2 mg NM injected 3×/week. The number
of animals surviving was counted daily. The NM dietary
treatment group (3) resulted in increased survival over the
control diet group (2) mice, as shown in the Kaplan–Meier
survival curve (Fig. 6). The longest survival time (22 days)
for groups was reached by a mouse in group 3, whose
survival was 5 days longer than that of group 2 mice.
Group 3 mice exhibited a mean increase in survival time of
1.4 days over that of group 2 mice, which showed a mean
survival time of 15.2 days versus 16.7 days for group 3
mice. Group 4 mice had a mean survival time of 15.2 days.
2.2 Nutrient synergy modulates various parameters critical
to metastasis: secretion of MMPS, uPA, tissue inhibitors
of metalloproteinases (TIMPs), cancer cell migration,
and Matrigel invasion
Proteasesplaya keyrole intumor cellinvasionandmetastasis
due to their ability to digest basement membrane and ECM
components. Two families of proteases: u-PA and MMPs-2
Fig. 5 Representative a spleens, b livers, and c spleen sections and d liver sections from Control and NM-supplemented nude mice receiving
intrasplenic injection of 10
6 B16FO cells
Organs Control group (n=5) mean organ weight (g) NM group (n=5) mean organ weight (g)
Spleen 2.76±0.77 0.989±0.151
Liver 4.59±1.5 2.08±0.185
Kidney 0.602±0.006 0.599±0.009
Lung 0.18±0.057 0.197±0.003
Table 2 Effect of 10
6 B16FO
cells administered into spleens
of male nude mice on mean
organ weights of groups control
group, regular diet post injec-
tion; NM group, NM 0.5%
supplemented diet post injection
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Strongclinicaland experimentalevidenceshows thatelevated
levels of u-PA and MMPs are associated with tumor growth,
cancer progression, metastasis, and shortened survival in
patients. MMP activities are regulated by specific TIMPs. U-
Pa and MMPS are expressed in many tumor cell lines.
Fig. 6 Effect of NM treatment on survival of C57BL/6 mice receiving
B16FO melanoma cells IP (Kaplan–Meier survival curve)
Fig. 7 Effect of NM on uninduced prostate PC-3 cell MMP-2 and
MMP-9 secretion (a) and on PMA (100 ng/ml)-treated PC-3 cell
MMP-2 and MMP-9 secretion (c). 1 markers, 2 control, 3–7 NM 10,
50, 100, 500, 1,000 μg/ml. Densitometric analyses of uninduced PC-3
cells (b) and PMA-treated PC-3 cells (d)
Fig. 8 Immunohistochemistry of human fibrosarcoma HT-1080 xeno-
grafts in male nude mice showing MMP9 levels a control group, b NM
supplemented group
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Using gelatinase zymography, we evaluated MMP-2 and
MMP-9 secretion in many cancer cell lines, some express-
ing only MMP-2 or MMP-9 and some expressing both.
Gelatinase zymography was performed in 10% Novex Pre-
Cast sodium dodecyl sulfate (SDS) Polyacrylamide Gel
(Invitrogen Corporation) in the presence of 0.1% gelatin
under non-reducing conditions. Culture media (20 μL) were
mixed with sample buffer and loaded for SDS-
polyacrylamide gel electrophoresis (PAGE) with Tris glycine
SDS buffer, as suggested by the manufacturer (Novex).
Samples were not boiled before electrophoresis. Following
electrophoresis,thegelswerewashedtwicein2.5%TritonX-
100 for 30 min at room temperature to remove SDS. The gels
were then incubated at 37°C overnight in substrate buffer
containing 50 mM Tris-HCl and 10 mM CaCl2 at pH 8.0 and
stained with 0.5% Coomassie Blue R250 in 50% methanol
and 10% glacial acetic acid for 30 min and destained. Upon
renaturation of the enzyme, the gelatinases digested the
gelatin in the gel, producing clear bands against an intensely
stained background. Protein standards were run concurrently
and approximate molecular weights were determined by
plotting the relative mobilities of known proteins. Gelatinase
zymograms were scanned using CanoScan 9950F scanner at
300 dpi.
Fig. 9 Effect of NM on prostate PC-3 cell u-PA secretion (a) and on
TIMPs secretion (c). 1 Markers, 2 control, 3–7 NM 10, 50, 100, 500,
1,000 μg/ml. Densitometric analyses of PC-3 u-PA secretion (b) and
TIMPs secretion (d). Correlation between: PC-3 u-PA and MMP-2
expression (e), PC-3 TIMP-2 and u-PA expression (f), PC-3 MMP-2
and TIMP-2 expression (g)
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cancer cells tested. Representative of a cancer cell line
expressing both MMP-2 and MMP-9, prostate cancer cell
line PC-3 is shown in Fig. 7. Zymography showed bands
representing MMP-2 and MMP-9 in normal and PMA-
treated PC-3 cells. NM inhibited secretion of both MMPs in
a dose-dependent manner.
Densitometry analysis of normal PC-3 secretion showed
100% inhibition of MMP-2 and MMP-9 at 500 μg/ml NM,
with linear trend of R
2=0.831 (MMP-2) and R
2=0.715
(MMP-9). For PMA-induced PC-3 cells, relative activity of
MMP-2 revealed 100% inhibition at 250 μg/ml NM, with
linear trend of R
2=0.750. MMP-9 relative density showed
100% inhibition at 500 μg/ml NM, with R
2=0.883 [38].
In vivo results also demonstrated modulation of MMP-9
secretion with NM treatment. Tumor tissue from xenograft
studies demonstrated reduction of MMP-9 secretion when the
mice were fed a diet supplemented with NM 0.5%. For
example, xenografts of human fibrosarcoma HT-1080 cells in
male athymic mice showed reduction of MMP-9 secretion
with NM supplementation, as shown in Fig. 8.S t a n d a r d
immunohistochemical staining procedures using polyclonal
rabbit anti-human antibodies were used for MMP-9.
2.2.2 Nutrient synergy increases TIMPS and decreases
u-PA activities
Studies of several cancer cell lines demonstrated down-
regulated activity of u-PA and up-regulated activity of
TIMPs. Cells were treated with NM at 0, 10, 50, 100, 500,
and 1,000 μg/ml. U-PA activity was analyzed by fibrin
zymography on 10% SDS-PAGE gels containing fibrinogen
Fig. 10 Effect of NM on migration of T-24 cells: scratch test. a Control pre-scratch, b control scratch, c control 24 h, d NM 50 μg/ml 24 h, e NM
100 μg/ml 24 h, f NM 250 μg/ml 24 h, g NM 500 μg/ml 24 h, h NM 1,000 μg/ml 24 h
Cancer Metastasis Rev (2010) 29:529–542 537(5.5 mg/mL) and plasminogen (50 μg/mL). After electro-
phoresis, the gels were washed twice with 2.5% Triton X-
100 for 30 min. The gels were then incubated overnight at
37°C with 0.1% glycine buffer pH 7.5 and then stained
with 0.5% Coomassie Brilliant Blue R250 and destained.
Electrophoresis of u-PA was conducted for comparison.
Fibrin zymograms were scanned using CanoScan 9950F
Canon Scanner. TIMPS were analyzed by reverse zymog-
raphy on 15% SDS gels containing serum-free conditioned
medium from cells. After electrophoresis the gels were
washed twice with 2.5% Triton-X for 30 min at room
temperature to remove SDS. The gels were then incubated
at 37° overnight in 50 mM Tris-HCl and 10 mM Ca Cl2 at
pH 7.6 and stained with 0.5% Coomassie Blue R25,
destained and scanned.
The results obtained with prostate PC-3 cell line,
presented here, are representative of findings for other cell
lines [38]. U-PA activity was detected in PC-3 prostate
cancer cell line, showing two bands corresponding to
molecular weights 35 and 33 kD. NM inhibited their
expression in a dose response manner, with significant
reduction in u-PA activity at 250 μg/ml NM (Fig. 9a–b).
Activity of TIMPs was upregulated in PC-3 in a dose-
dependent manner (Fig. 9c–d). Minimum activity was
expressed at 50 μg/ml and maximum at 1,000 μg/ml.
Analysis revealed a positive correlation (r=0.977) between
PC-3 u-PA and MMP expression (Fig. 9e), a negative
correlation (r=−0.939) between expression of u-PA and
TIMP-2 (Fig. 9f) and a negative correlation (r=−0.781)
between MMPs and TIMP-2 (Fig. 9g).
2.2.3 Nutrient synergy has inhibitory effect on cancer cell
migration
To study cell migration, a 2-mm wide single uninterrupted
scratch was made from top to bottom of culture plates of
cancer cells grown to confluence. Culture plates were
washed with phosphate-buffered saline (PBS) and incubat-
ed with NM in medium and tested at 0, 10, 50, 100, 500,
and 1,000 μg/ml in triplicate at each dose for 24 h. Cells
were washed with PBS, fixed and stained with H&E and
photomicrographs were taken. A representative example is
shown with bladder cancer cells [39]. NM reduced bladder
cancer cell line T-24 cell migration in a dose-dependent
fashion, with total inhibition at 1,000 μg/ml (Fig. 10).
2.2.4 Nutrient synergy inhibits Matrigel invasion by cancer
cells
Invasion studies were conducted on many cancer cell lines
using Matrigel (Becton Dickinson) inserts in 24-well plates.
Table 3 summarizes the concentration of NM required to
completely block Matrigel invasion in a variety of cancer
cell lines. Suspended in medium, cancer cells were
supplemented with nutrients, as specified in the design of
the experiments and seeded on the insert in the well. Thus,
both the medium on the insert and in the well contained the
same supplements. The plates with the inserts were then
incubated in a culture incubator equilibrated with 95% air
and 5% CO2 for 24 h. After incubation, the media from the
wells were withdrawn. The cells on the upper surface of
the inserts were gently scrubbed away with cotton swabs.
The cells that had penetrated the Matrigel membrane and
migrated onto the lower surface of the Matrigel were
stained with hematoxylin and eosin and visually counted
under the microscope.
A representative example is the effect of NM on bladder
cancer cell line T-24. NM significantly inhibited T-24 cell
invasion through Matrigel in a dose-dependent manner,
with 60% (p=0.0006) at 50 μg/ml, 81% (p=0.0002) at
100 μg/ml, 95% (p=0.0001) inhibition at 500 μg/ml and
100% (p=0.0001) at 1,000 μg/ml NM compared to control
[39]. There was significant negative correlation between
NM concentration and number of T-24 cells that invaded/
migrated through Matrigel: r=−0.6955, p=0.001 (Fig. 11).
Table 3 Effect of NM on cancer cell Matrigel invasion
Cancer cell line NM concentration to achieve
100% block of ECM
invasion (μg/mL)
Breast (MBA-MB-231) 100
Breast (MCF-7 estrogen sensitive)
+estradiol
100
Osteosarcoma (MNNG/U2OS) 100
Cervical cancer HeLa 500
Lung carcinoma (A-549) 500
Pancreas (MIA PACA-2) 500
Prostate (LNCaP) 500
Colon (HCT 116) 500
Rhabdomyosarcoma 500
Prostate (DU-145) 500
Thyroid SW 579 500
Hepatocellular carcinoma SK-Hep-1 1,000
Bladder Cancer (T-24) 1,000
Fibrosarcoma HT1080 1,000
Cervical Cancer (DoTc2451) 1,000
Ovarian SK-OV-3 1,000
Prostate PC-3 1,000
Renal carcinoma 786-0 1,000
Synovial carcinoma 1,000
Melanoma A2058 1,000
Glioma A-172 1,000
Liposarcoma SW-872 1,000
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and induces apoptosis
ECM degradation is a prerequisite for cancer metastasis,
but also it is essential to tumor growth and expansion and
angiogenesis. Therefore, we investigated the effects of
nutrient synergy on these important aspects of malignancy.
2.3.1 Inhibition of tumor growth (xenografts)
NM has been shown to modulate xenograft tumor growth in
a variety of cancer cell lines. Table 4 presents results we
obtained with some of these cell lines. For example, male
athymic mice 6 weeks of age (n=12) were inoculated
subcutaneously with 3×10
6 A2058 cells in 0.2 ml PBS and
0.1 ml Matrigel. After injection, the mice were randomly
divided into two groups; group A mice were fed regular
Purina mouse chow and group B the regular diet supple-
mented with 0.5% NM (w/w). After 4 weeks, the mice were
sacrificed and their tumors were excised and processed for
histology. Dimensions (length and width) of tumors were
measured using a digital caliper, and the tumor burden was
calculated using the following formula: 0.5×length×width.
Mean weight of mice at initiation of study and termination
of study did not differ significantly between the groups.
The melanoma xenograft study showed that NM supple-
mentation inhibited tumor weight by 57% (p<0.0001) and
tumor burden by 31% over control diet.
2.3.2 Decreased cancer cell proliferation in the presence
of nutrient synergy
We evaluated the effect of various concentrations of NM on
the viability of various cancer cell lines utilizing the [3-
(4,5-dimethylthiazol-2-yl) 2,5-diphenyl tetrazolium bro-
mide] MTT assay, a colorimetric assay based on the ability
of viable cells to reduce a soluble yellow tetrazolium salt
MTT to a blue formazan crystal by mitochondrial succinate
dehydrogenase activity of viable cells. This test is a good
index of mitochondrial activity and thus of cell viability.
Inhibition of cell proliferation was confirmed in a variety of
cancer cell lines, as shown in Table 5.
2.3.3 Induction of cancer cell apoptosis by nutrient synergy
We investigated pro-apoptotic effects of nutrient synergy in
various types of tumors using the following tests: live green
caspases, DNA fragmentation, expression of pro-apoptotic
genes, and cell cycle. An example of live green caspace test
is described below. To study the effect of NM on apoptosis
of cancer cells, cells were grown to confluence, challenged
Table 4 Effect of NM diet on tumor weight and burden in xenograft
studies
Cancer cell line Reduction of tumor
weight by NM diet
over control diet
Reduction of tumor
burden by NM diet
over control diet
SK-Hep-1 42% (p=0.09) 36% (p=0.005)
Colon HCT-116 63% (p=0.0002) 46% (p=0.0005)
Prostate PC-3 47% (P<0.0001) 53% (p=0.0002)
Lung A-549 44% (p=0.001) 47% (p<0.0001)
Melanoma A2058 57% (p<0.0001) 31%
Table 5 Effect of NM on cancer cell proliferation
Cancer cell line Percent Inhibition of
cell growth at NM
1,000μg/mL
Breast (MBA-MB-231) 50%
Breast (MCF-7 estrogen sensitive)+estradiol 25%
Osteosarcoma (MNNG) 10%
Cervical cancer HeLa 37%
Lung carcinoma (A-549) 20%
Pancreas (MIA PACA-2) 38%
Prostate (LNCaP) 80%
Osteosarcoma (U2OS) 60%
Rhabdomyosarcoma 20%
Prostate (DU-145) 47%
Hepatocellular carcinoma SK-Hep-1 33%
Fibrosarcoma HT1080 37%
Cervical Cancer (DoTc2451) 45%
Prostate PC-3 40%
Synovial carcinoma 28%
Melanoma A2058 64%
Glioma A-172 50%
Liposarcoma SW-872 61%
Fig. 11 Effect of NM on Matrigel invasion of T-24 cells
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1,000 μg/ml and incubated for 24 h. The cell culture was
washed with PBS and treated with the caspase reagent as
specified in the manufacturer’s protocol (Molecular Probes
Image-IT™ Live Green Poly Caspases Detection Kit
135104, Invitrogen). The cells were photographed under a
fluorescence microscope and counted. Green-colored cells
represent viable cells, while yellow orange represents early
apoptosis and red, late apoptosis. Dose-dependent induction
of apoptosis in a variety of cancer cell lines was confirmed
with NM challenge. The effect of NM on apoptosis in
rhabdosarcoma cells is shown in Fig. 12 [40]. At 100 μg/ml
NM, 95% of cells were viable and 5% in apoptosis, at
250 μg/ml NM, 46% were viable, 13% in early apoptosis
and 41% in late apoptosis, at 500 μg/ml NM, 28% of cells
were viable, 14% in early apoptosis, and 58% in late
apoptosis. Virtually all cells exposed to 1,000 μg/ml NM
were apoptotic. Quantitative analysis of live, early and late
apoptotic cells is shown in Fig. 13. Studies by Harakeh et
al. [41] have shown that NM induces apoptosis of adult T-
cell leukemia cells and acute leukemia cells by the
modulation of p53, p21, Bcl-2 and Bax protein levels.
2.3.4 Nutrient synergy modulates cancer cell cycle
We also studied the effect of NM on cell cycle in cancer
cells since disregulation of the cell cycle components may
lead to tumor formation. As an example, melanoma cells A-
2058 were cultured in a 6-well plate at a concentration of
0.5×106 cells per well. The cells were incubated with NM
Fig. 12 Effect of NM on apoptosis of rhabdomyosarcoma cells: live-green caspases a control, b NM 50 μg/ml, c NM 100 μg/ml, d NM 250 μg/
ml, e NM 500 μg/ml, f NM 1,000 μg/ml
Fig. 13 Quantitative analysis of live, early and late apoptotic cells Fig. 14 Effect of NM on cell cycle of melanoma A-2058 cells
540 Cancer Metastasis Rev (2010) 29:529–542at 0, 10, 100, and 1,000 μg/ml for 24 h and harvested. The
cells were washed once with PBS and fixed in 70% ethanol.
Cell pellets were suspended in 2 μLo f1 0μg/ml RNase
containing 0.5% Triton and the same volume of 20 μg/ml
propidium iodide, followed by incubation in the dark at
room temperature for 30 min. Cell fluorescence was
measured in the Coulter EPIC Flow Cytometer. Melanoma
A-2058 cells exposed to NM showed dose-dependent
increase of % of cells in the G-1 phase and decrease in
G-2 and G-3 phases, indicating decrease in cells ready to
undergo mitosis. See Fig. 14. Earlier studies also indicated
cell cycle arrest of adult T-cell leukemia and acute leukemia
cells by NM [41].
2.4 Nutrient synergy modulates Cox-2 expression in cancer
cells
Inflammatory proteins such as Cox-2 contribute to carcino-
genesis of human tumors and have been found to be elevated
in cancer patients. Cox-2 proteins were determined by
Western blot analysis using polyclonal antibodies against
Cox-2. Briefly, the cell were lysed for 30 min in ice cold
radioimmunoprecipitation buffer (50 mM Tris-HCl, pH 7.5,
10% Triton X-100, 1.0% Na-deoxycholate, 150 mM NaCl,
2 mM EDTA) with 1 mM activated orthovandate, and 1×
Complete Mini Protease Inhibitor Cocktail tablet. Clarified
cell lysates were denatured and equal proteins loaded and
fractionated by SDS-polyacrylamide gel electrophoresis.
After electrophoresis, the proteins were transferred to nitro-
cellulose membrane. The membranes were then incubated
with the respective antibodies and developed by the enhanced
chemiluminescence system. We found Cox-2 expression by
bladder cancer T-24 cells exposed to NM to be reduced in a
dose-dependent fashion [39]. A study of the effect of another
micronutrient mixture including ascorbic acid, quercetin,
naringenin, hesperitin, tea catechins, lysine, proline, arginine,
and N-acetyl cysteine on inflammatory gene expression
found that this mixture inhibited Cox-2 enzymatic activity
and down regulated pro-inflammatory cytokine protein
expression at the transcription level complementing a
blockade in NFkβ activation [42].
3 Safety of NM
In contrast to the toxic side effects of current treatments, the
micronutrient mixture has been shown to be a safe
therapeutic agent. In a previous in vivo study addressing
safety issues, we found that gavaging adult female ODS
rats (weighing 250–300 g) with the nutrient mixture (at 30,
90, or 150 mg per day for 7 days), had neither adverse
effects on vital organs (heart, liver, and kidney), nor on the
associated functional serum enzymes, indicating that this
mixture is safe to use even at these high doses, which far
exceed the normal equivalent dosage of the nutrient [43].
4 Conclusions
In conclusion, the synergistic micronutrient mixture has been
shown to be effective against multiple targets in cancer
development and progression. These results indicate that this
non-toxic comprehensive approach should be considered in
cancer therapy as a safe and economical approach.
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